PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 29, 2007New England Journal of Medicine1,736 citationsOpen Access

Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

View Full Paper
LMLeslie W. MillerFPFrancis D. PaganiSRStuart D. Russell

Key Points

  • This research aims to evaluate the effectiveness of a continuous-flow left ventricular assist device in improving hemodynamic support for patients awaiting heart transplantation.
  • Continuous-flow left ventricular assist device utilized for hemodynamic support for at least 6 months.
  • ClinicalTrials.gov registration number NCT00121472.
  • Patients experienced improved functional status and quality of life during the support period.
  • Effective hemodynamic support was provided over the minimum duration of 6 months.

Abstract

A continuous-flow left ventricular assist device can provide effective hemodynamic support for a period of at least 6 months in patients awaiting heart transplantation, with improved functional status and quality of life. (ClinicalTrials.gov number, NCT00121472 ClinicalTrials.gov.).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Miller et al. (2007) studied this question.

synapsesocial.com/papers/69effab7bce9831ba4f73c82https://doi.org/10.1056/nejmoa067758
Ask AI
Helpful
Bookmark
Share
View Full Paper